The U.S. Food and Drug Administration on Thursday proposed excluding active ingredients for Novo Nordisk and Eli Lilly’s weight-loss drugs on the list of drugs outsourcing facilities can use for compounding. If finalized, the exclusion would limit compounding of these…[#item_full_content]
La Flotilla attracca a Venezia. “I palestinesi sono molto più che una bandiera”
Settembre 7, 2026
Read More [#item_full_content]
